Page 24 - Envision-05-2022

THE

YOUNGER OPTICS RELEASES
NUPOLAR POLARIZED LENSES IN
1.74 HIGH INDEX MATERIAL

uPolar is now available in a 1.74 high index
Nmaterial, allowing eyecare providers across the
globe to offer NuPolar quality to high-prescription
patients in an ultra-thin sunwear lens.
“The eyecare industry is always happy when Younger
expands its NuPolar line of polarized lenses,”
says David Rips, president and CEO of Younger
Optics. “Labs especially prefer NuPolar lenses
because while other polarized lenses vary in quality
BAUSCH + LOMB RECEIVES HEALTH and performance, NuPolar consistently outperforms
CANADA APPROVAL OF LUMIFY REDNESS other products during processing.”
RELIEVER EYE DROPS NuPolar 1.74 lenses are manufactured MR-174 resin,
ausch + Lomb Corporation announced that a high-performance material with good processing
BHealth Canada has approved LUMIFY and stability characteristics. NuPolar 1.74 is offered
(brimonidine tartrate ophthalmic solution 0.025% in four base curves with precise film placement to
w/v), the first and only over-the-counter (OTC) allow for minimum thickness over a very wide Rx
eye drop developed with low-dose brimonidine range (-13.00 D to +9.00 D). They come with all the
tartrate to relieve redness of the eye due to minor eye features that make NuPolar unique: excellent heat
irritations for adults. stability, superb adhesion characteristics, consistent
true curve control, high polarization efficiency,
“With Health Canada’s approval of LUMIFY, we are unrivaled colour uniformity, and of course they are
excited to be able to now offer Canadians a new option backed by the NuPolar warranty. NuPolar 1.74 SFSV
to help relieve their red, irritated eyes,” said Joe lenses can be processed digitally or with traditional
Gordon, president, Global Consumer, Surgical and processing equipment.
Vision Care. NuPolar polarized lenses contain a polarized film
Eye redness occurs as a result of minor eye irritations that selectively blocks polarized light, which means
such as environmental allergies, dryness and fatigue. that blinding glare is almost completely absorbed
LUMIFY works by selectively targeting redness and while information-carrying light can pass.
thereby reducing the potential for side effects such
as rebound redness and tachyphylaxis. In clinical Eyecare practices can now offer their patients with
trials, LUMIFY eye drops demonstrated significant high plus and high minus prescriptions polarized
reduction in ocular redness seen as early as one sunwear with thinner lenses, which reduces the
minute and persisted up to eight hours. An in-home- weight of the eyewear and generally looks more
use study with over 300 participants also resulted in attractive in the frame.
a 95 per cent satisfaction rating for the product. NuPolar 1.74 SFSV lenses are currently available in
“Ocular redness is often one of the first things people gray; they be also be available in brown in the near
notice when making eye contact. It can affect daily future.
life and have a negative social impact, especially for
important occasions such as critical meetings
or events,” said Riyad Khamis, O.D., FAAO,
FCOVD, London, Ontario. LUMIFY is expected to
be available at all major pharmacy retailers in Canada
by July 2022 in both 3.5 mL and 7.5 mL size formats.

22 / MAY - JUNE 2022 / www.ENVISIONMAGAZINE.ca /